SUCCINYLCHOLINE CHLORIDE (SUCCINYLCHOLINE CHLORIDE) — FDA Approval ANDA211346 (FRESENIUS KABI USA)
SUCCINYLCHOLINE CHLORIDE (SUCCINYLCHOLINE CHLORIDE) — FDA Approval ANDA211346 (FRESENIUS KABI USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SUCCINYLCHOLINE CHLORIDE; Active ingredients: SUCCINYLCHOLINE CHLORIDE; Application number: ANDA211346.
| Brand name | SUCCINYLCHOLINE CHLORIDE |
|---|---|
| Active ingredients | SUCCINYLCHOLINE CHLORIDE |
| Application number | ANDA211346 |
| Sponsor | FRESENIUS KABI USA |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20201120 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →